+++ 350 % MÖGLICH IN SEHR KURZER +++ - 500 Beiträge pro Seite
eröffnet am 08.10.04 10:21:31 von
neuester Beitrag 14.10.04 21:27:13 von
neuester Beitrag 14.10.04 21:27:13 von
Beiträge: 56
ID: 912.257
ID: 912.257
Aufrufe heute: 0
Gesamt: 2.037
Gesamt: 2.037
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 1 Stunde | 10627 | |
| vor 46 Minuten | 7345 | |
| vor 41 Minuten | 4260 | |
| vor 42 Minuten | 3861 | |
| vor 49 Minuten | 3452 | |
| vor 49 Minuten | 3449 | |
| heute 18:22 | 2640 | |
| vor 1 Stunde | 2626 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.045,00 | +0,17 | 241 | |||
| 2. | 34. | 1,3800 | -1,43 | 93 | |||
| 3. | 2. | 9,3175 | -3,84 | 83 | |||
| 4. | 3. | 160,91 | +6,30 | 77 | |||
| 5. | 4. | 0,1920 | -1,79 | 73 | |||
| 6. | 14. | 6,9910 | +4,02 | 53 | |||
| 7. | 13. | 414,55 | +1,41 | 45 | |||
| 8. | 6. | 0,0262 | +24,17 | 38 |
Feedback
Zeit
Es gibt seit vorgestern einen Optionsplan mit 10 Millionen Aktien zu 0.75 (= ca. 350 % )
FORM S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
MED GEN, INC.
(Exact name of issuer as specified in its charter)
Nevada 65-0703559
------------------------------- -------------------
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
7284 W. Palmetto Park Road, Suite 207
Boca Raton, Florida 33433
(Address of principal executive offices)
NONQUALIFIED STOCK OPTION PLAN
(Full title of the Plan)
Paul S. Mitchell, President
Med Gen, Inc.
7284 W. Palmetto Park Road, Suite 207
Boca Raton, Florida 33433 (561) 750-1100
(Name, address and telephone number of agent for service)
Approximate date of commencement of sales pursuant to the Plan:
Immediately after the effective date of this Registration Statement.
CALCULATION OF REGISTRATION FEE
-----------------------------------------------------------------------------------------------
Title of Securities Amount to be Proposed Maximum Proposed Maximum Total
to be Registered (1) Offering Price per Aggregate Offering Registration
Registered Share (a) Price Fee
-----------------------------------------------------------------------------------------------
Common stock 10,000,000 $0.75 (2) $7,500,000 $950.25
-----------------------------------------------------------------------------------------------
(1) If, as a result of stock splits, stock dividends, or similar transactions, the number of securities purported to be registered on
--------------------------------------------------------------------------------
this registration statement changes, the provisions of Rule 416 shall apply to this registration statement, and this registration statement shall cover the additional securities resulting from such split, dividend or similar transaction.
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act of 1933, as amended, and computed on the basis of $.75 per share exercise price of options granted to purchase 10,000,000 shares of common stock of the Registrant.
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed to register 10,000,000 shares of common stock for issuance upon the exercise of options granted or to be granted pursuant to the Registrant`s Non- Qualified Stock Option Plan.
Pursuant to Rule 428(b)(1), promulgated under the Securities Act of 1933, as amended (the "Securities Act"), the information required by Part I of Form S-8 will be sent or given to employees, as specified in such Rule, in the form of a prospectus that meets the requirements of
Section 10(a) of the Securities Act. In accordance with the instructional Note to Part I of Form S-8, the information specified by Part I of Form S-8 has been omitted from this Registration Statement on Form S-8 for offers of Common Stock pursuant to the Plan.
leich kommen weitere Einzelheiten und einen Letter to Shareholders
Es gibt seit vorgestern einen Optionsplan mit 10 Millionen Aktien zu 0.75 (= ca. 350 % )
FORM S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
MED GEN, INC.
(Exact name of issuer as specified in its charter)
Nevada 65-0703559
------------------------------- -------------------
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
7284 W. Palmetto Park Road, Suite 207
Boca Raton, Florida 33433
(Address of principal executive offices)
NONQUALIFIED STOCK OPTION PLAN
(Full title of the Plan)
Paul S. Mitchell, President
Med Gen, Inc.
7284 W. Palmetto Park Road, Suite 207
Boca Raton, Florida 33433 (561) 750-1100
(Name, address and telephone number of agent for service)
Approximate date of commencement of sales pursuant to the Plan:
Immediately after the effective date of this Registration Statement.
CALCULATION OF REGISTRATION FEE
-----------------------------------------------------------------------------------------------
Title of Securities Amount to be Proposed Maximum Proposed Maximum Total
to be Registered (1) Offering Price per Aggregate Offering Registration
Registered Share (a) Price Fee
-----------------------------------------------------------------------------------------------
Common stock 10,000,000 $0.75
(2) $7,500,000 $950.25-----------------------------------------------------------------------------------------------
(1) If, as a result of stock splits, stock dividends, or similar transactions, the number of securities purported to be registered on
--------------------------------------------------------------------------------
this registration statement changes, the provisions of Rule 416 shall apply to this registration statement, and this registration statement shall cover the additional securities resulting from such split, dividend or similar transaction.
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act of 1933, as amended, and computed on the basis of $.75 per share exercise price of options granted to purchase 10,000,000 shares of common stock of the Registrant.
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed to register 10,000,000 shares of common stock for issuance upon the exercise of options granted or to be granted pursuant to the Registrant`s Non- Qualified Stock Option Plan.
Pursuant to Rule 428(b)(1), promulgated under the Securities Act of 1933, as amended (the "Securities Act"), the information required by Part I of Form S-8 will be sent or given to employees, as specified in such Rule, in the form of a prospectus that meets the requirements of
Section 10(a) of the Securities Act. In accordance with the instructional Note to Part I of Form S-8, the information specified by Part I of Form S-8 has been omitted from this Registration Statement on Form S-8 for offers of Common Stock pursuant to the Plan.
leich kommen weitere Einzelheiten und einen Letter to Shareholders
Hier vom CEO vom 04.10.2004
DATE: October 4, 2004
SUBJECT: A NEW ERA
I believe that we are fast approaching a new era in the way we invest in companies, protect our assets and spend our money. No longer will we be able to trust that Government will take care of us in our old age…. And certainly, as we are now finding out, no longer are we going to rely upon industry or Government to completely take care of our healthcare needs. So where do we go from here?
Once there was a line in a song that went, “For every drop of rain that falls, a flower grows”. The message is clear, the raindrop is a dollar and the flower is our future. In their wondrous wisdom, the SEC enacted or forced the enactment of the “financial reporting” of all trading companies and instituted the Sarbanes-Oxley Act, making it almost impossible to create sin at the expense of the shareholder. That being so, the risk of investing in “long shots”, “start-ups”, “micro-caps” and developing companies becomes one of knowing the product(s), the management and the capital availability. In the end, investing in these companies will provide the monetary growth necessary to provide for ones old age and healthcare.
Years ago it was the dinosaur called the “Savings Account”, Government Bonds and various forms of money-market accounts. One could hardly keep pace with the increasing cost of living using any of these mediums.
My point with all this is that I am increasingly alarmed as I visit the chat rooms and watch the posts as they predict stock gyrations, company news releases and new store openings. To what end? Pumping up stocks only to see them fall again serves little purpose, as I see it the gain of one day can easily be the loss in the next… and so forth, ad infinitum. I have witnessed Med Gen rise from $0.10 to $0.19 only to fall to $0.15 by the close. If a companies stock is a mirror to its value, how can the same company be worth $2 million in the morning and $1 million by the afternoon? Further, the roller coaster rise and fall of the shares create a massive short position forcing market-makers to alter positions at the expense of creating an orderly market, which just happens to be their intended purpose.
Humbly I submit, if everybody that invested in the AM put their stock away for 6 months, allowing the company to perform, increase its value and thus their share price, the market would dry-up the shorts, the shares would rise as the value of the company increases, savings would increase and everyone’s individual wealth would increase to the point that they wouldn’t need government help. Sure, betting on the right horse is important… but that is the risk that is inherent in all forms of life. It’s the same risk we take when we choose to fly to a destination… And we all take that risk gladly, rather than drive long distances.
I have taken the time to write these thoughts because I love this company and its products. Seven years ago, while searching for a way to stop my own snoring affliction I discovered Snorenz®, invested my own money to commercialize the product and then built Med Gen around the brand, the rest is history. The claims that I have made regarding our products, and the company has published are true and accurate. Being accused and being guilty, as one knows are quite different. The FTC matter regarding Apnea claims was brought about by a third party during an infomercial TV show and was never purported by either myself or the company to be true. Nevertheless, we accepted the “slap-on-the-hand” and we are still here. Two years later, at great expense, we have completed the biggest and best study yet. Done by a recognized Otolaryngology specialist at a Sleep Center at Northside Hospital, Atlanta Georgia, Snorenz was pronounced, once and for all, “an effective alternative to surgery or other medical treatment, for reducing the noise caused by snoring”.
Hey, if we can all agree that we have the product, and almost everyone snores [whether we admit it or not]. Does Med Gen have a long term future? You bet it has! News Releases, Stories, new store openings aside these releases are for public information purposes only, not meant to pump sales. The company will eventually grow and prosper on its own, grow beyond imagination…grow because of its products and the demand for its products.
Think about it this way. If Wal Mart, Walgreens, Gristedes, CVS, Meijers, Osco Drug, Albertsons, Acme Supermarkets, and others stock these products…. Are their buyers crazy?
Now, make up your minds… we need long term players. Join us while we explore the markets of the world. Let’s make the drop of rain fall.
My best.
Paul B. Kravitz
Chairman/CEO
In Ruhe durchlesen - und die Shares 6 Monate bei Seite legen
DATE: October 4, 2004
SUBJECT: A NEW ERA
I believe that we are fast approaching a new era in the way we invest in companies, protect our assets and spend our money. No longer will we be able to trust that Government will take care of us in our old age…. And certainly, as we are now finding out, no longer are we going to rely upon industry or Government to completely take care of our healthcare needs. So where do we go from here?
Once there was a line in a song that went, “For every drop of rain that falls, a flower grows”. The message is clear, the raindrop is a dollar and the flower is our future. In their wondrous wisdom, the SEC enacted or forced the enactment of the “financial reporting” of all trading companies and instituted the Sarbanes-Oxley Act, making it almost impossible to create sin at the expense of the shareholder. That being so, the risk of investing in “long shots”, “start-ups”, “micro-caps” and developing companies becomes one of knowing the product(s), the management and the capital availability. In the end, investing in these companies will provide the monetary growth necessary to provide for ones old age and healthcare.
Years ago it was the dinosaur called the “Savings Account”, Government Bonds and various forms of money-market accounts. One could hardly keep pace with the increasing cost of living using any of these mediums.
My point with all this is that I am increasingly alarmed as I visit the chat rooms and watch the posts as they predict stock gyrations, company news releases and new store openings. To what end? Pumping up stocks only to see them fall again serves little purpose, as I see it the gain of one day can easily be the loss in the next… and so forth, ad infinitum. I have witnessed Med Gen rise from $0.10 to $0.19 only to fall to $0.15 by the close. If a companies stock is a mirror to its value, how can the same company be worth $2 million in the morning and $1 million by the afternoon? Further, the roller coaster rise and fall of the shares create a massive short position forcing market-makers to alter positions at the expense of creating an orderly market, which just happens to be their intended purpose.
Humbly I submit, if everybody that invested in the AM put their stock away for 6 months, allowing the company to perform, increase its value and thus their share price, the market would dry-up the shorts, the shares would rise as the value of the company increases, savings would increase and everyone’s individual wealth would increase to the point that they wouldn’t need government help. Sure, betting on the right horse is important… but that is the risk that is inherent in all forms of life. It’s the same risk we take when we choose to fly to a destination… And we all take that risk gladly, rather than drive long distances.
I have taken the time to write these thoughts because I love this company and its products. Seven years ago, while searching for a way to stop my own snoring affliction I discovered Snorenz®, invested my own money to commercialize the product and then built Med Gen around the brand, the rest is history. The claims that I have made regarding our products, and the company has published are true and accurate. Being accused and being guilty, as one knows are quite different. The FTC matter regarding Apnea claims was brought about by a third party during an infomercial TV show and was never purported by either myself or the company to be true. Nevertheless, we accepted the “slap-on-the-hand” and we are still here. Two years later, at great expense, we have completed the biggest and best study yet
. Done by a recognized Otolaryngology specialist at a Sleep Center at Northside Hospital, Atlanta Georgia, Snorenz was pronounced, once and for all, “an effective alternative to surgery or other medical treatment, for reducing the noise caused by snoring”. Hey, if we can all agree that we have the product, and almost everyone snores [whether we admit it or not]. Does Med Gen have a long term future? You bet it has! News Releases, Stories, new store openings aside these releases are for public information purposes only, not meant to pump sales. The company will eventually grow and prosper on its own, grow beyond imagination…grow because of its products and the demand for its products.
Think about it this way. If Wal Mart, Walgreens, Gristedes, CVS, Meijers, Osco Drug, Albertsons, Acme Supermarkets, and others stock these products…. Are their buyers crazy?
Now, make up your minds… we need long term players. Join us while we explore the markets of the world. Let’s make the drop of rain fall.
My best.
Paul B. Kravitz
Chairman/CEO
In Ruhe durchlesen - und die Shares 6 Monate bei Seite legen
Irgendwo habe ich gelesen, daß für den Oktober weitere News kommen sollen, kanns aber im Moment nicht finden
Hier dafür der Chart
Man sieht sehr deutlich, wie Medgen runtergeprügelt wurde und nun wieder hochzieht in Richtung Norden. Exakt an der 200 Tagelinie liegen die 0.75. Gehts da durch, wovon ich ausgehen, greifen die Optionen
Hier dafür der Chart
Man sieht sehr deutlich, wie Medgen runtergeprügelt wurde und nun wieder hochzieht in Richtung Norden. Exakt an der 200 Tagelinie liegen die 0.75. Gehts da durch, wovon ich ausgehen, greifen die Optionen
Vor 1 Jahr lagen wir noch bei knapp 6 Dollar
Und die Aussichten sind besser denn je zuvor
Auf die WL setzen und beobachten
Und die Aussichten sind besser denn je zuvor
Auf die WL setzen und beobachten
Hier noch das USA-Orderbuch Man sieht eine deutliche starke BID-Seite der größten MM`s, die in meine Augen auch am meisten geshortet haben dürften und jetzt noch sammeln müssen.
MMID Bid Bid Size MMID Ask Ask Size
MDGN Bullet Quote PulseChart
SCHB 0.160 50 MAXM 0.170 50
NITE 0.160 50 HILL 0.180 50
BAMM 0.160 50 TDCM 0.190 50
MAXM 0.160 50 NITE 0.190 50
JEFF 0.154 50 BAMM 0.190 50
CRWN 0.150 50 CRWN 0.200 50
GVRC 0.150 50 HDSN 0.200 50
HILL 0.150 50 JEFF 0.206 50
AGIS 0.140 50 SCHB 0.210 50
HDSN 0.130 50 SEAB 0.215 50
MRLN 0.125 50 AGIS 0.220 50
SEAB 0.125 50 VIEW 0.220 50
SACM 0.125 50 MRLN 0.230 50
TDCM 0.120 50 BWNC 0.250 50
VFIN 0.120 50 GVRC 0.250 50
FRAN 0.115 50 VFIN 0.250 50
DOMS 0.101 50 SACM 0.250 50
PERT 0.101 50 BEST 0.250 50
SBSH 0.100 50 FLCR 0.270 50
VIEW 0.080 50 FRAN 0.270 50
WDCO 0.080 50 SBSH 0.300 50
BWNC 0.070 50 WDCO 0.300 50
BEST 0.070 50 PERT 0.310 50
FLCR 0.050 50 DOMS 0.350 50
Die rechte Seite beginnend mit den 0.17 stellt die ASK-Seite dar. Liegt nicht wirklich viel drin bis zu 0.20.
Man sieht eine deutliche starke BID-Seite der größten MM`s, die in meine Augen auch am meisten geshortet haben dürften und jetzt noch sammeln müssen.MMID Bid Bid Size MMID Ask Ask Size
MDGN Bullet Quote PulseChart
SCHB 0.160 50 MAXM 0.170 50
NITE 0.160 50 HILL 0.180 50
BAMM 0.160 50 TDCM 0.190 50
MAXM 0.160 50 NITE 0.190 50
JEFF 0.154 50 BAMM 0.190 50
CRWN 0.150 50 CRWN 0.200 50
GVRC 0.150 50 HDSN 0.200 50
HILL 0.150 50 JEFF 0.206 50
AGIS 0.140 50 SCHB 0.210 50
HDSN 0.130 50 SEAB 0.215 50
MRLN 0.125 50 AGIS 0.220 50
SEAB 0.125 50 VIEW 0.220 50
SACM 0.125 50 MRLN 0.230 50
TDCM 0.120 50 BWNC 0.250 50
VFIN 0.120 50 GVRC 0.250 50
FRAN 0.115 50 VFIN 0.250 50
DOMS 0.101 50 SACM 0.250 50
PERT 0.101 50 BEST 0.250 50
SBSH 0.100 50 FLCR 0.270 50
VIEW 0.080 50 FRAN 0.270 50
WDCO 0.080 50 SBSH 0.300 50
BWNC 0.070 50 WDCO 0.300 50
BEST 0.070 50 PERT 0.310 50
FLCR 0.050 50 DOMS 0.350 50
Die rechte Seite beginnend mit den 0.17 stellt die ASK-Seite dar. Liegt nicht wirklich viel drin bis zu 0.20.
Trading Spotlight
Orderbuch in Berlin
Med Gen. Inc.
Skontroführer: MWB Wertpapierhandelshaus AG (1172)
Best Bid
Volumen Taxe
- 0,13
Kauf Orders
Stücke Limit
50.000 0,111
5.000 0,11
3.000 0,095
7.000 0,085
- -
Weitere: 0
Best Ask
Taxe Volumen
0,18 -
Verkauf Orders
Limit Stücke
0,21 10.000
0,29 2.800
- -
- -
- -
Weitere: 0
ISIN: US58401X2099
WKN: A0CABE
Tagesübersicht
akt. Spread in %: 38,46
Letzter Preis: 0,15
Uhrzeit: 10:31:00
Umsatz (Stück): 4.100
Preise gesamt: 2
Umsatz gesamt: 4.100
Statistik
Tageshoch: 0,15
Tagestief: 0,11
Diff. in %: +42,857
Diff. abs.: +0,045
Eröffnungspreis: 0,15
Schluß Vortag: 0,105
Schlußkurs in USA entspricht in etwa 0.14 Euro
Also laßt Euch von den 45 % Plus nicht blenden und holt Euch die Shares in USA
Med Gen. Inc.
Skontroführer: MWB Wertpapierhandelshaus AG (1172)
Best Bid
Volumen Taxe
- 0,13
Kauf Orders
Stücke Limit
50.000 0,111
5.000 0,11
3.000 0,095
7.000 0,085
- -
Weitere: 0
Best Ask
Taxe Volumen
0,18 -
Verkauf Orders
Limit Stücke
0,21 10.000
0,29 2.800
- -
- -
- -
Weitere: 0
ISIN: US58401X2099
WKN: A0CABE
Tagesübersicht
akt. Spread in %: 38,46
Letzter Preis: 0,15
Uhrzeit: 10:31:00
Umsatz (Stück): 4.100
Preise gesamt: 2
Umsatz gesamt: 4.100
Statistik
Tageshoch: 0,15
Tagestief: 0,11
Diff. in %: +42,857
Diff. abs.: +0,045
Eröffnungspreis: 0,15
Schluß Vortag: 0,105
Schlußkurs in USA entspricht in etwa 0.14 Euro
Also laßt Euch von den 45 % Plus nicht blenden und holt Euch die Shares in USA
Kauft nicht über 0,135.
Das ist der Kurs bei den Amis.
Ich denke nachdem die Pharmas zur Zeit schlecht dastehen, werden die heute nochmals runtergeprügelt.
Mein Kauf wäre bei 0,11 €.
Das ist der Kurs bei den Amis.
Ich denke nachdem die Pharmas zur Zeit schlecht dastehen, werden die heute nochmals runtergeprügelt.
Mein Kauf wäre bei 0,11 €.
Dann bist Du der mit den 50k im BID
0.11 Euro kannst Dir abschminken
0.11 Euro kannst Dir abschminken
Und warum sollte es bitte schön 350% hoch gehen? Das wären 0,50 Euro. Ist das ein typischer Zock oder wirklich fundamental begründet?
News kommen auf jeden Fall noch im Oktober.
Vom 27.August:
The opening of other major retail chains throughout the United States will be announced by management for both Good Nights Sleep(R) and Snorenz(R) during September and October.
Vom 28. September:
Other new store openings will be announced shortly, both in the United States and abroad. Increasing gross sales to $2.5 million is our absolute minimum goal for our next fiscal year ending in September 2005 said Mr. Kravitz.
Das Management war bisher immer verlässlich und hat Wort gehalten. Deshalb rechne ich jeden Tag mit einer Nachricht, die mindestens 100% bringen wird.
Vom 27.August:
The opening of other major retail chains throughout the United States will be announced by management for both Good Nights Sleep(R) and Snorenz(R) during September and October.
Vom 28. September:
Other new store openings will be announced shortly, both in the United States and abroad. Increasing gross sales to $2.5 million is our absolute minimum goal for our next fiscal year ending in September 2005 said Mr. Kravitz.
Das Management war bisher immer verlässlich und hat Wort gehalten. Deshalb rechne ich jeden Tag mit einer Nachricht, die mindestens 100% bringen wird.
Seht Euch die letzten News an
Danke Siffel
Danke Siffel
Es gibt seit vorgestern einen Optionsplan mit 10 Millionen Aktien zu 0.75
nein, daß steht in dem filing ganz bestimmt nicht. es gilt das gleiche wie bei jedem S-8 seit ewigkeiten auch schon...
nein, daß steht in dem filing ganz bestimmt nicht. es gilt das gleiche wie bei jedem S-8 seit ewigkeiten auch schon...
Press releases Coming NEXT week
That`s right..............
TWO NEw releases coming so hold on to your hats..Called CEO and he stated that news will come next week
Two importnat developments so hold your positions and get ready for Tuesday takeoff!!!
DOn`t you love the ROLLER Coaster in this stock!!
Aus dem Ragingbullforum. Soll sich jeder selber seine Meinung zu bilden!
That`s right..............
TWO NEw releases coming so hold on to your hats..Called CEO and he stated that news will come next week
Two importnat developments so hold your positions and get ready for Tuesday takeoff!!!
DOn`t you love the ROLLER Coaster in this stock!!
Aus dem Ragingbullforum. Soll sich jeder selber seine Meinung zu bilden!
O. KEVIN TRUDEAU: Wenn Sie ein snorer sind oder wissen, daß jemand das heißt, es das Schnarchen gerade wie das beseitigt, zurück garantiert oder Ihr Geld. Es ist ein patentierter Prozeß, double-blind Studien, klinische Forschung. Wenn es nicht funktioniert, schicken Sie es für eine volle Rückerstattung zurück, keine gestellten Fragen. Aber die Statistiken zeigen, 97 Prozent wirkungsvoll im Beseitigen der Geräusche von schnarchen die allererste Anwendung. Völker, Ihr Leben können geändert werden, wenn Sie einen Rest der gute Nacht erhalten.
http://translate.google.com/translate?hl=de&sl=en&u=http://w…
Quipu
http://translate.google.com/translate?hl=de&sl=en&u=http://w…
Quipu
Was ist denn hier heute los.... Bei den Amis 0,16, bei uns 0,21.... die spinnen, die Römer!
Sieht doch gut aus. Für Morgen werden im Raginbullboard auf News spekuliert mit denen wir die 0,3$ knacken sollten.
Hätte ich nichts gegen!
Wie usxp wär nicht schlecht
Wie usxp wär nicht schlecht
Erfolg absehbar!
Antischnarchspray mit 97 Prozent Wirksamkeit :
http://translate.google.com/translate?hl=de&sl=en&u=http://w…
Davon sprechen wir:
http://translate.google.com/translate?hl=de&sl=en&u=http://w…
Zu erhalten auch bei Amazon:
http://www.amazon.com/exec/obidos/tg/detail/-/B000062WTU/102…
Letzte Meldung:
http://translate.google.com/translate?hl=de&sl=en&u=http://b…
Weitere Erfolgsmeldungen werden folgen.
Man sollte jetzt auf den Zug aufspringen, bevor er richtige Geschwindigkeit aufnimmt!
Quipu
Antischnarchspray mit 97 Prozent Wirksamkeit :
http://translate.google.com/translate?hl=de&sl=en&u=http://w…
Davon sprechen wir:
http://translate.google.com/translate?hl=de&sl=en&u=http://w…
Zu erhalten auch bei Amazon:
http://www.amazon.com/exec/obidos/tg/detail/-/B000062WTU/102…
Letzte Meldung:
http://translate.google.com/translate?hl=de&sl=en&u=http://b…
Weitere Erfolgsmeldungen werden folgen.
Man sollte jetzt auf den Zug aufspringen, bevor er richtige Geschwindigkeit aufnimmt!
Quipu
An Alle
Vielleicht sehen wir noch 2€ dieses Jahr,wenn man bedenkt das Sie 2003 bei 5€ Stand !!!
Vielleicht sehen wir noch 2€ dieses Jahr,wenn man bedenkt das Sie 2003 bei 5€ Stand !!!
Und 2002 und in der Spitze 2003 noch über 40,00 USD !!!
Antischnarchspray mit 97 Prozent Wirksamkeit !!!
Werbekampgne ist in großem Stil angelaufen !!!
Verkauf verzögert, aber jetzt geht es los !!!!!
Große Ketten werden nachziehen !!!!
Täglich können neue Meldungen kommen !!!!
Quipu
Werbekampgne ist in großem Stil angelaufen !!!
Verkauf verzögert, aber jetzt geht es los !!!!!
Große Ketten werden nachziehen !!!!
Täglich können neue Meldungen kommen !!!!
Quipu
Lass uns erstmal mit 2€ anfangen dan 5€ und danach können wir alle Urlaub machen
Med Gen has distributors to sell its alternate brands of the snoring spray in
Canada,
the United Kingdom,
Germany,
France,
Switzerland,
Portugal,
Turkey,
Australia,
New Zealand,
Japan,
China,
Korea.
Quipu
Canada,
the United Kingdom,
Germany,
France,
Switzerland,
Portugal,
Turkey,
Australia,
New Zealand,
Japan,
China,
Korea.
Quipu
RINCIPAL STOCKHOLDERS: December 15, 2003,
Paul B. Kravitz owned or controlled 51.3% of the Common, and Paul S. Mitchell 25.4%
Quipu
Paul B. Kravitz owned or controlled 51.3% of the Common, and Paul S. Mitchell 25.4%
Quipu
wow
Eine Fundgrube für die Gesundheit und eine Garantie für
eine gesunde Zukunft !!!
http://www.thehealthytimes.com/index.htm
Quipu
Eine Fundgrube für die Gesundheit und eine Garantie für
eine gesunde Zukunft !!!
http://www.thehealthytimes.com/index.htm
Quipu
Nicht zu vergessen, daß Med Gen nächstes Jahr noch ihr Schmerzmittel in Form eines Halssprays auf den Markt bringt. Meiner Ansicht hat dieses Produkt noch weitaus größeres Potenzial als Snorenz.
Press Release Source: Med Gen Inc.
Med Gen Ready to Enter $2 Billion Analgesic Market
Monday August 30, 8:00 am ET
BOCA RATON, Fla.--(BUSINESS WIRE)--Aug. 30, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray and Good Nights Sleep®, sleep aid throat spray, announced today that it intends to make an early release on a new analgesic spray formula catering to both adults and children that find it difficult to take pills.
The "Spray`s the Way" technology that Med Gen has spearheaded these past 5 years is showing signs of enormous growth potential. Med Gen management believes that by taking ownership to this niche business it can successfully navigate its products onto the shelves of major retailers as an alternate to the large array of products that now compete in pill and caplet formats. The advantage to Med Gen`s throat spray technology is that it is easier to use, is absorbed quickly into the blood stream for maximum effect and caters to the "Pill Hater" population that just cannot swallow pills easily. Med Gen`s management has set its goal at a conservative 1% market share, which would mean an additional $20 million in sales. This goal could be achieved within 12-36 months of its entrance into the market.
Med Gen`s Painenz Spray(TM) will contain Ibuprofen, which is a nonsteroidal anti-inflammatory drug, more commonly classified as an NSAID. In effect, Painenz Spray(TM) will provide relief from pain, tenderness, inflammation and stiffness and will be used to treat osteoarthritis, rheumatoid arthritis, gout and even painful menstruation.
Med Gen`s "Spray`s The Way" unique delivery system provides the practical alternative to pills, caplets and syrups. The adult version has a pleasant fresh minty flavor and the easy to take children`s version will taste like fruity bubble gum.
Press Release Source: Med Gen Inc.
Med Gen Ready to Enter $2 Billion Analgesic Market
Monday August 30, 8:00 am ET
BOCA RATON, Fla.--(BUSINESS WIRE)--Aug. 30, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray and Good Nights Sleep®, sleep aid throat spray, announced today that it intends to make an early release on a new analgesic spray formula catering to both adults and children that find it difficult to take pills.
The "Spray`s the Way" technology that Med Gen has spearheaded these past 5 years is showing signs of enormous growth potential. Med Gen management believes that by taking ownership to this niche business it can successfully navigate its products onto the shelves of major retailers as an alternate to the large array of products that now compete in pill and caplet formats. The advantage to Med Gen`s throat spray technology is that it is easier to use, is absorbed quickly into the blood stream for maximum effect and caters to the "Pill Hater" population that just cannot swallow pills easily. Med Gen`s management has set its goal at a conservative 1% market share, which would mean an additional $20 million in sales. This goal could be achieved within 12-36 months of its entrance into the market.
Med Gen`s Painenz Spray(TM) will contain Ibuprofen, which is a nonsteroidal anti-inflammatory drug, more commonly classified as an NSAID. In effect, Painenz Spray(TM) will provide relief from pain, tenderness, inflammation and stiffness and will be used to treat osteoarthritis, rheumatoid arthritis, gout and even painful menstruation.
Med Gen`s "Spray`s The Way" unique delivery system provides the practical alternative to pills, caplets and syrups. The adult version has a pleasant fresh minty flavor and the easy to take children`s version will taste like fruity bubble gum.
Hallo Siffel,
bin ganz Deiner Meinung, wo siehst Du das Langfristige Kurziel von MDGN.
Bei Weltweit ca. 300-400Mio Schnarchern und einem Marktanteil von vieleicht konservativen 1-3%, und 1% beim Schmerzmittel (ca. 20Mio $ Umsatz) komme ich auf einen Gesamtumsatz von ca. 110Mio $.
Wobei mann hier mit einem Gewinn von ca. 20Mio $ rechnen kann ?????? und das mit einer derzeitigen Marktkap. von gerade mal 3,6Mio $.
bin ganz Deiner Meinung, wo siehst Du das Langfristige Kurziel von MDGN.
Bei Weltweit ca. 300-400Mio Schnarchern und einem Marktanteil von vieleicht konservativen 1-3%, und 1% beim Schmerzmittel (ca. 20Mio $ Umsatz) komme ich auf einen Gesamtumsatz von ca. 110Mio $.
Wobei mann hier mit einem Gewinn von ca. 20Mio $ rechnen kann ?????? und das mit einer derzeitigen Marktkap. von gerade mal 3,6Mio $.
An Alle
Wenn das Schnarchspray in ganz USA verteilt ist und Die Kunden zufrieden sind dan sind Kusre um die 10€ - ??? 2005
möglich. Das ist meine Meinung seht Ihr das auch so ??
Wenn das Schnarchspray in ganz USA verteilt ist und Die Kunden zufrieden sind dan sind Kusre um die 10€ - ??? 2005
möglich. Das ist meine Meinung seht Ihr das auch so ??
:Hallo ecos.
Glaube nicht, daß man das so einfach berechnen kann. In Deutschland gibt es z.B. auch ein Antischnarchspray auf dem Markt, daß nach dem gleichen Konzept funktioniert, heißt auch irgendwie so ähnlich wie Snorenz, habe ich selber schon in der Apotheke stehen sehen, ist aber leider nicht von Med Gen.
Die Marktherrschaft in den USA würde ja erstmal reichen, da gibt es soweit ich weiß nur ein Konkurenzprodukt.
Colasorten gibt es z.B. ja auch ohne Ende, trotzdem macht Coca Cola Riesengewinne. Alles eine Frage der Marketingstrategie und genau hieran wird bei Med Gen ja kräftig gearbeitet.
Mein persönliches Kursziel ist erstmal 0,5$. Was durchaus schon nach der nächsten Meldung eintreten könnte!(Vielleicht ja schon heute)
Halte dieses Jahr bei weiteren positiven Nachrichten aber 1$ durchaus für möglich, wobei zwischendurch mit Sicherheit wieder einige Talfahrten eintreten werden.
Ist halt OTCBB, da ist sowas an der Tagesordnung.
Glaube nicht, daß man das so einfach berechnen kann. In Deutschland gibt es z.B. auch ein Antischnarchspray auf dem Markt, daß nach dem gleichen Konzept funktioniert, heißt auch irgendwie so ähnlich wie Snorenz, habe ich selber schon in der Apotheke stehen sehen, ist aber leider nicht von Med Gen.
Die Marktherrschaft in den USA würde ja erstmal reichen, da gibt es soweit ich weiß nur ein Konkurenzprodukt.
Colasorten gibt es z.B. ja auch ohne Ende, trotzdem macht Coca Cola Riesengewinne. Alles eine Frage der Marketingstrategie und genau hieran wird bei Med Gen ja kräftig gearbeitet.
Mein persönliches Kursziel ist erstmal 0,5$. Was durchaus schon nach der nächsten Meldung eintreten könnte!(Vielleicht ja schon heute
)Halte dieses Jahr bei weiteren positiven Nachrichten aber 1$ durchaus für möglich, wobei zwischendurch mit Sicherheit wieder einige Talfahrten eintreten werden.
Ist halt OTCBB, da ist sowas an der Tagesordnung.
ich glaube sogar das nach den ersten Verkaufszahlen, Kurse von bis zu 2 Dollar möglich sind (die allgemeine Übertreibung an der OTC)
Kursziele bei der OTCBB anzugeben ist halt irgendwie Blödsinn, da ist wirklich alles möglich.
Quartalszahlen müssten ja bald kommen. Soweit ich weiß endet das Geschäftsjahr von Med Gen am 31.09, danach hat man 90 Tage Zeit das die entsprechenden Filings zu veröffentlichen.
Das letzte Quartal müsste nach den letzten Meldungen zufolge ganz gut gewesen sein,aber ob dadurch das gesamte Geschäftsjahr glattgebügelt werden kann weiß ich nicht.
Quartalszahlen müssten ja bald kommen. Soweit ich weiß endet das Geschäftsjahr von Med Gen am 31.09, danach hat man 90 Tage Zeit das die entsprechenden Filings zu veröffentlichen.
Das letzte Quartal müsste nach den letzten Meldungen zufolge ganz gut gewesen sein,aber ob dadurch das gesamte Geschäftsjahr glattgebügelt werden kann weiß ich nicht.
BOCA RATON, Fla.--(BUSINESS WIRE)--Oct. 12, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray and Good Nights Sleep®, sleep aid throat spray, announced today that its sales for the month ending September 30th, 2004 were $101,352. Sales for September have exceeded monthly sales over the past four months and indicate very positive growth as a result of the advertising campaigns that were implemented in April. The normally quiet summer months are now giving way to the company`s most profitable seasons, fall and winter.
Paul Kravitz, company Chairman and Chief Executive, in a telephone conference with investment professionals went on to explain that the company shows other important signs of healthy growth. In a comparison of September 2003 with preliminary and unaudited September 2004 numbers, the company has dramatically increased its operating income by $89,000 and in doing so has reached "break even" on an operating basis. This is a result of an intensive reduction in costs associated with legal, general overhead and rent. Secondly, the company went from a negative shareholders equity of $881,000 to a positive shareholders equity of $355,000, a swing of $1.23 million and lastly, current liabilities were reduced from $1,918,267 to $267,034, a reduction of $1.65 million.
As a result of the tremendous improvement in the company`s financial position, management feels that it has positioned the company for expansive growth as it enters its eighth year. New store openings, a healthy capital position and reduced overhead all spell success.
This Press Release contains or incorporates by reference "forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN".
--------------------------------------------------------------------------------
Contact:
Med Gen Inc., Boca Raton
Paul B. Kravitz, 561-750-1100
Web Site: http://www.medgen.com
--------------------------------------------------------------------------------
Source: Med Gen Inc.
Paul Kravitz, company Chairman and Chief Executive, in a telephone conference with investment professionals went on to explain that the company shows other important signs of healthy growth. In a comparison of September 2003 with preliminary and unaudited September 2004 numbers, the company has dramatically increased its operating income by $89,000 and in doing so has reached "break even" on an operating basis. This is a result of an intensive reduction in costs associated with legal, general overhead and rent. Secondly, the company went from a negative shareholders equity of $881,000 to a positive shareholders equity of $355,000, a swing of $1.23 million and lastly, current liabilities were reduced from $1,918,267 to $267,034, a reduction of $1.65 million.
As a result of the tremendous improvement in the company`s financial position, management feels that it has positioned the company for expansive growth as it enters its eighth year. New store openings, a healthy capital position and reduced overhead all spell success.
This Press Release contains or incorporates by reference "forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN".
--------------------------------------------------------------------------------
Contact:
Med Gen Inc., Boca Raton
Paul B. Kravitz, 561-750-1100
Web Site: http://www.medgen.com
--------------------------------------------------------------------------------
Source: Med Gen Inc.
Schätze nach diesem Turbulenten Jahr, werden die Zahlen vor Ende November nicht kommen. Vieleicht ist dann aber ein Trend schon erkennbar.
Wnn der Kurs weiter steigt werden Zahlen gut sein
hört sich gut an !!!!
Bin mal gespannt, wie die Amis darauf reagieren, von 0,15$ bis 0,7$ ist alles möglich!!
wenn in US die 0,23 geknackt wird, schätze ich positiv.
Die News sind ja wirklich nicht schlecht, und bei uns glauben immer noch ein Paar sie können in Berlin oder Frankfurt für 0,12 abstauben.
Die News sind ja wirklich nicht schlecht, und bei uns glauben immer noch ein Paar sie können in Berlin oder Frankfurt für 0,12 abstauben.
Und das Beste ist, daß die News über zwei neue Ladeneröffnungen noch ausstehen.Rechne jeden Tag damit.
es geht los bid in US bei 0,20 ask bei 0,24
Bid 0,23 - Ask 0,26
Bid 0,25 - Ask 0,30
Die geht ja richtig ab heute positive News ????
positive News ????
Na also geht doch
Von der Hompage
From the Chairman
AN OPEN LETTER TO ALL SHAREHOLDERS AND THE GENERAL PUBLIC
Nobody benefits when rumors dictate the movement of stock or the direction of a company. While it is true that most stocks trade on “future hope” and some hype, it is also true that the personality of a real company should be based upon fact, calculated predictions and honesty.
It is often said that life is shaped by events… and to a great degree I believe that there is truth to that adage. Med Gen is now seven years old. Most companies don’t make it past the three-year mark. So you must believe that we have great products, great management or both. We certainly never had the benefit of a lot of money. The biggest single event that is now shaping our destiny is the lawsuit that has been recently announced in a News Release by the company and which has been discussed ad nauseum in almost every chat room on the Internet.
Let me clarify for all, the future events that are apt to take place and the possible effects on our company. Mind you, the attitude of management is “business as usual”. You have been made aware of significant progress in marketing, distribution and R&D efforts to bring out new and exciting products. This massive effort on the part of management will no doubt make Med Gen an exciting and highly prosperous company. Yet we must get over the legal problems in order to build immediate shareholder loyalty and long-term investors.
With regard to the lawsuit, there are several events going on at the same time. There is a (i) “motion for a new trial”, (ii) negotiation for settlement, (iii) Appeal for a new trial on damage award and (iv) filing prepared for protection under the chapter 11 bankruptcy code. None of these events, other than a negotiated settlement, would happen before March 2005 and maybe, in the case of an Appeal until early 2006. The company’s legal team will protect us all during the process, leaving management free to run the company [not that I don’t worry a lot- and oversee the process]. The point is, to make a “buy” or “no buy” decision at this point purely on the speculative outcome of the legal action does not make much sense. As the gurus say, buy low sell high. If you as an investor feel that our stock at this level is undervalued, this could well be the buying opportunity of a lifetime.
Disclaimers aside, Snorenz® and Good Night’s Sleep® are products of unparallel value with huge market potential. Did you know that the combined domestic markets for these products exceed $1.6 billion? You should also know that Good Night’s Sleep is unique in that it has no competition as a liquid spray sleep-aid…Snorenz® has only one competitor and Snorenz® is the only all natural snore-relief brand, an original patented formula that has been proven over 7 years and major studies to do what it says it will do. We are a company with real products, sold in major stores throughout the USA and soon in major markets World-Wide. Need I say more!
From the Chairman
AN OPEN LETTER TO ALL SHAREHOLDERS AND THE GENERAL PUBLIC
Nobody benefits when rumors dictate the movement of stock or the direction of a company. While it is true that most stocks trade on “future hope” and some hype, it is also true that the personality of a real company should be based upon fact, calculated predictions and honesty.
It is often said that life is shaped by events… and to a great degree I believe that there is truth to that adage. Med Gen is now seven years old. Most companies don’t make it past the three-year mark. So you must believe that we have great products, great management or both. We certainly never had the benefit of a lot of money. The biggest single event that is now shaping our destiny is the lawsuit that has been recently announced in a News Release by the company and which has been discussed ad nauseum in almost every chat room on the Internet.
Let me clarify for all, the future events that are apt to take place and the possible effects on our company. Mind you, the attitude of management is “business as usual”. You have been made aware of significant progress in marketing, distribution and R&D efforts to bring out new and exciting products. This massive effort on the part of management will no doubt make Med Gen an exciting and highly prosperous company. Yet we must get over the legal problems in order to build immediate shareholder loyalty and long-term investors.
With regard to the lawsuit, there are several events going on at the same time. There is a (i) “motion for a new trial”, (ii) negotiation for settlement, (iii) Appeal for a new trial on damage award and (iv) filing prepared for protection under the chapter 11 bankruptcy code. None of these events, other than a negotiated settlement, would happen before March 2005 and maybe, in the case of an Appeal until early 2006. The company’s legal team will protect us all during the process, leaving management free to run the company [not that I don’t worry a lot- and oversee the process]. The point is, to make a “buy” or “no buy” decision at this point purely on the speculative outcome of the legal action does not make much sense. As the gurus say, buy low sell high. If you as an investor feel that our stock at this level is undervalued, this could well be the buying opportunity of a lifetime.
Disclaimers aside, Snorenz® and Good Night’s Sleep® are products of unparallel value with huge market potential. Did you know that the combined domestic markets for these products exceed $1.6 billion? You should also know that Good Night’s Sleep is unique in that it has no competition as a liquid spray sleep-aid…Snorenz® has only one competitor and Snorenz® is the only all natural snore-relief brand, an original patented formula that has been proven over 7 years and major studies to do what it says it will do. We are a company with real products, sold in major stores throughout the USA and soon in major markets World-Wide. Need I say more!
Wie ist den der RT in USA ?? Danke
10:05:45 0.200 7500 OTCBB
10:01:34 0.200 1500 OTCBB
10:01:31 0.200 5000 OTCBB
10:01:19 0.200 5000 OTCBB
10:01:11 0.200 5000 OTCBB
10:00:19 0.200 5000 OTCBB
09:58:57 0.200 3500 OTCBB
09:58:57 0.200 4000 OTCBB
09:57:20 0.205 5000 OTCBB
09:57:06 0.205 5000 OTCBB
10:01:34 0.200 1500 OTCBB
10:01:31 0.200 5000 OTCBB
10:01:19 0.200 5000 OTCBB
10:01:11 0.200 5000 OTCBB
10:00:19 0.200 5000 OTCBB
09:58:57 0.200 3500 OTCBB
09:58:57 0.200 4000 OTCBB
09:57:20 0.205 5000 OTCBB
09:57:06 0.205 5000 OTCBB
Warum geht der Kurs nicht nach oben !!! 
Nur Geduld, die Aktie hat halt ne unheimliche Dynamik undzwar in beide Richtungen. Langfristig(damit meine ich 6-12 Monate) wird sich hier noch einiges tun. Im Juni standen wir noch bei 1,25$ und da sah es lange nicht so gut aus wie jetzt. Was schwer auf MDGN lastet ist immer noch das laufende Gerichtsverfahren, wonach sie 2,2 Mio.$ an ihren ehemaligen Vertreiber zahlen sollen. Die Firma wehrt sich aber mit Zähnen und hat bereits einen neuen Vergleich beantragt, da der alte nach Meinung des Managments höchst ungerecht war. Sollte dieser Vergleich zu Gunsten MDGN ausgehen, sehen wir am gleichen Tag noch 1$,da bin ich mir sicher.
Sollte alles schiefgehen,so dauert es dennoch Jahre, bis da Geld entgültig bezahlt werden muss.
Wenn das Geschäftsmodell von MDGN weiterhin so aufgeht wie die letzten Monate, dann wird ihnen selbst diese Zahlung noch lange nicht das Genick brechen.
Sollte alles schiefgehen,so dauert es dennoch Jahre, bis da Geld entgültig bezahlt werden muss.
Wenn das Geschäftsmodell von MDGN weiterhin so aufgeht wie die letzten Monate, dann wird ihnen selbst diese Zahlung noch lange nicht das Genick brechen.
Mit Ruhe und Gemütlichkeit - wird schon
Was mich stört, ist der hoch angesetzte Kurs (MM`s?) bei uns gegenüber dem Amiland. Es kann doch nicht sein, dass hier einer so teuer kaufen will, wenn er die Teile bei den Amis günstiger bekommt.
Glaube, daß wir nochmals etwas tiefer testen, sodaß wenn man wartet vielleicht nochmals zu 0.12 oder so welche bekommt?
MAXM ist auf der BID-Seite von 0.155 auf 0.165 gezogen
NITE jetzt auch oben im BID und Orderbuch wird dünner
Es geht demnächst wieder extrem ab
Es geht demnächst wieder extrem ab
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 241 | ||
| 93 | ||
| 83 | ||
| 77 | ||
| 73 | ||
| 53 | ||
| 45 | ||
| 38 | ||
| 37 | ||
| 34 |
| Wertpapier | Beiträge | |
|---|---|---|
| 33 | ||
| 30 | ||
| 26 | ||
| 25 | ||
| 24 | ||
| 24 | ||
| 24 | ||
| 23 | ||
| 19 | ||
| 19 |
